CSIMarket
 


Pepgen Inc   (PEPG)
Other Ticker:  
 
 

PEPG's Net Income Growth by Quarter and Year

Pepgen Inc 's Net Income results by quarter and year




PEPG Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -14.94 0.00 0.00
III Quarter September -23.29 -18.61 0.00 0.00
II Quarter June -19.52 -17.32 0.00 0.00
I Quarter March -16.32 -18.25 0.00 0.00
FY   -59.13 -69.12 0.00 0.00



PEPG Net Income third quarter 2023 Y/Y Growth Comment
Pepgen Inc in the third quarter 2023 recorded net loss of $ -23.29 millions.

According to the results reported in the third quarter 2023, Pepgen Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Pepgen Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter 2023.




PEPG Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Pepgen Inc 's third quarter 2023 Net Income $ -23.29 millions PEPG's Income Statement
Pepgen Inc 's third quarter 2022 Net Income $ -18.61 millions Quarterly PEPG's Income Statement
New: More PEPG's historic Net Income Growth >>


PEPG Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Pepgen Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PEPG's III. Quarter Q/Q Net Income Comment
Recent results of -23.29 millions by Pepgen Inc look even less good compare to the -19.52 millions a quarter before.

Within Major Pharmaceutical Preparations industry Pepgen Inc achieved highest sequential Net Income growth. While Pepgen Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PEPG's III. Quarter Q/Q Net Income Comment
Current net loss of -23.29 millions by Pepgen Inc come out even worse considering the -19.52 millions a quarter before.

Within Major Pharmaceutical Preparations industry Pepgen Inc achieved highest sequential Net Income growth. While Pepgen Inc 's Net Income growth quarter on quarter, overall rank is .


Pepgen Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Net Income 12 Months Ending $ -74.07 $ -69.38 $ -67.18 $ -69.10 $ 0.00
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Pepgen Inc ' has realized cumulative trailing twelve months net loss of $ -74 millions in the Sep 30 2023 period.
The business is worsening as the cumulative net loss is inflating from $ -69.38 millions in TTM ending quarter Jun 30 2023 and $ millions for the twelve months ending in the quarter a year ago.

Pepgen Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Pepgen Inc ' has realized cumulative trailing twelve months net loss of $ -74 millions in the Sep 30 2023 period.
The business is detiriorating as the cumulative net loss is inflating from $ -69.38 millions in TTM ending quarter Jun 30 2023 and $ millions for the twelve months ending in the quarter a year ago.

Pepgen Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
PEPG's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for PEPG's Competitors
Net Income Growth for Pepgen Inc 's Suppliers
Net Income Growth for PEPG's Customers

You may also want to know
PEPG's Annual Growth Rates PEPG's Profitability Ratios PEPG's Asset Turnover Ratio PEPG's Dividend Growth
PEPG's Roe PEPG's Valuation Ratios PEPG's Financial Strength Ratios PEPG's Dividend Payout Ratio
PEPG's Roa PEPG's Inventory Turnover Ratio PEPG's Growth Rates PEPG's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2023
Ir med Inc 37.73%$ 37.734 millions
Lemaitre Vascular Inc 37.50%$ 37.500 millions
West Pharmaceutical Services Inc 33.75%$ 33.748 millions
Addus Homecare Corporation33.51%$ 33.509 millions
Halozyme Therapeutics Inc 32.78%$ 32.779 millions
Chemed Corporation31.80%$ 31.799 millions
Intuitive Surgical Inc 29.29%$ 29.289 millions
Gilead Sciences Inc 21.61%$ 21.613 millions
Neurocrine Biosciences Inc 21.31%$ 21.314 millions
Docgo Inc 20.50%$ 20.505 millions
Progyny Inc 20.34%$ 20.339 millions
Bristol myers Squibb Company20.27%$ 20.274 millions
Dexcom Inc 19.27%$ 19.269 millions
Idexx Laboratories Inc17.29%$ 17.295 millions
Biomx Inc 16.61%$ 16.608 millions
Ensign Group Inc13.74%$ 13.737 millions
Zoetis Inc 12.88%$ 12.879 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com